Literature DB >> 31765788

Effect of PEGylation on the biological properties of cationic carbosilane dendronized gold nanoparticles.

Andrea Barrios-Gumiel1, Javier Sánchez-Nieves2, Elzbieta Pedziwiatr-Werbicka3, Viktar Abashkin4, Natallia Shcharbina5, Dzmitry Shcharbin4, Sława Glińska6, Karol Ciepluch7, Dorota Kuc-Ciepluch7, Dominika Lach8, Maria Bryszewska8, Rafael Gómez9, F Javier de la Mata10.   

Abstract

Heterofunctionalized gold nanoparticles (AuNPs) were obtained in a one pot reaction of gold precursor with cationic carbosilane dendrons (first to third generations, 1-3G) and (polyethylene)glycol (PEG) ligands in the presence of a reducing agent. The final dendron/PEG proportion on AuNPs depends on the initial dendron/PEG ratio (3/1, 1/1, 1/3) and dendron generation. AuNPs were characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), ultraviolet spectroscopy (UV-VIS), thermogravimetric analysis (TGA), nuclear magnetic resonance (1H NMR) and zeta potential (ZP). Several assays have been carried out to determine the relevance of PEG/dendron ratio and dendron generation in the biomedical properties of PEGylated AuNPs and the results have been compared with those obtained for non-PEGylated AuNPs. Finally, analyses of PEG recognition by anti-PEG antibodies were carried out. In general, haemolysis, platelet aggregation and toxicity were reduced after PEGylation of AuNPs, the effect being dependent on dendron generation and dendron/PEG ratio. Dendron generation determines the exposure of PEG ligand and the interaction of this ligand with AuNPs environment. On the other hand, increasing PEG proportion diminishes toxicity but also favors interaction with antibodies.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carbosilane dendron; Gold nanoparticles; Haemolysis; PEG; PEG-antibody; Platelets aggregation; Toxicity

Mesh:

Substances:

Year:  2019        PMID: 31765788     DOI: 10.1016/j.ijpharm.2019.118867

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.

Authors:  Sylwia Michlewska; Maksim Ionov; Aleksandra Szwed; Aneta Rogalska; Natalia Sanz Del Olmo; Paula Ortega; Marta Denel; Damian Jacenik; Dzmitry Shcharbin; Francisco Javier de la Mata; Maria Bryszewska
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

Review 2.  Effects and treatment applications of polymeric nanoparticles on improving platelets' storage time: a review of the literature from 2010 to 2020.

Authors:  Tahereh Zadeh Mehrizi; Sedigheh Amini Kafiabad; Peyman Eshghi
Journal:  Blood Res       Date:  2021-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.